Global Cancer Mouse Models Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cancer Mouse Models Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 144

Published Date: 02 Jan 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

According to our (Global Info Research) latest study, the global Cancer Mouse Models market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the Cancer Mouse Models industry chain, the market status of Contract Research Organizations (Humanized Immune System Mouse Models, Syngeneic Tumor Mouse Models), Pharma and Biopharma Companies (Humanized Immune System Mouse Models, Syngeneic Tumor Mouse Models), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cancer Mouse Models.

Regionally, the report analyzes the Cancer Mouse Models markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cancer Mouse Models market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Cancer Mouse Models market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cancer Mouse Models industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Humanized Immune System Mouse Models, Syngeneic Tumor Mouse Models).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cancer Mouse Models market.

Regional Analysis: The report involves examining the Cancer Mouse Models market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cancer Mouse Models market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Cancer Mouse Models:
Company Analysis: Report covers individual Cancer Mouse Models players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cancer Mouse Models This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Contract Research Organizations, Pharma and Biopharma Companies).

Technology Analysis: Report covers specific technologies relevant to Cancer Mouse Models. It assesses the current state, advancements, and potential future developments in Cancer Mouse Models areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cancer Mouse Models market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Cancer Mouse Models market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Humanized Immune System Mouse Models
Syngeneic Tumor Mouse Models
Immunodeficient Mouse Models
NOG Mouse Models
Spontaneous Tumor Mouse Models
Others

Market segment by Application
Contract Research Organizations
Pharma and Biopharma Companies
Academic and Research Institutes

Market segment by players, this report covers
The Jackson Laboratory
Taconic Biosciences
Charles River Laboratories
Shanghai Model Organisms Center Inc.
Envigo
Biocytogen
Genoway
Crown Bioscience Inc. (JSR Corporation).
Cyagen
Applied stem cells
Ingenious Targeting Laboratory
PolyGene - Transgenic mice model company
Creative Biolabs
TransCure Bioservices
Champions Oncology Inc
Certis Oncology
Signature
Pharmaron
Laboratory Corporation of America Holdings
Gempharmatech
Janvier Labs
Harbour BioMed

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cancer Mouse Models product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cancer Mouse Models, with revenue, gross margin and global market share of Cancer Mouse Models from 2019 to 2024.
Chapter 3, the Cancer Mouse Models competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cancer Mouse Models market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Mouse Models.
Chapter 13, to describe Cancer Mouse Models research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Cancer Mouse Models
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cancer Mouse Models by Type
1.3.1 Overview: Global Cancer Mouse Models Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Cancer Mouse Models Consumption Value Market Share by Type in 2023
1.3.3 Humanized Immune System Mouse Models
1.3.4 Syngeneic Tumor Mouse Models
1.3.5 Immunodeficient Mouse Models
1.3.6 NOG Mouse Models
1.3.7 Spontaneous Tumor Mouse Models
1.3.8 Others
1.4 Global Cancer Mouse Models Market by Application
1.4.1 Overview: Global Cancer Mouse Models Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Contract Research Organizations
1.4.3 Pharma and Biopharma Companies
1.4.4 Academic and Research Institutes
1.5 Global Cancer Mouse Models Market Size & Forecast
1.6 Global Cancer Mouse Models Market Size and Forecast by Region
1.6.1 Global Cancer Mouse Models Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Cancer Mouse Models Market Size by Region, (2019-2030)
1.6.3 North America Cancer Mouse Models Market Size and Prospect (2019-2030)
1.6.4 Europe Cancer Mouse Models Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Cancer Mouse Models Market Size and Prospect (2019-2030)
1.6.6 South America Cancer Mouse Models Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Cancer Mouse Models Market Size and Prospect (2019-2030)

2 Company Profiles
2.1 The Jackson Laboratory
2.1.1 The Jackson Laboratory Details
2.1.2 The Jackson Laboratory Major Business
2.1.3 The Jackson Laboratory Cancer Mouse Models Product and Solutions
2.1.4 The Jackson Laboratory Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 The Jackson Laboratory Recent Developments and Future Plans
2.2 Taconic Biosciences
2.2.1 Taconic Biosciences Details
2.2.2 Taconic Biosciences Major Business
2.2.3 Taconic Biosciences Cancer Mouse Models Product and Solutions
2.2.4 Taconic Biosciences Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Taconic Biosciences Recent Developments and Future Plans
2.3 Charles River Laboratories
2.3.1 Charles River Laboratories Details
2.3.2 Charles River Laboratories Major Business
2.3.3 Charles River Laboratories Cancer Mouse Models Product and Solutions
2.3.4 Charles River Laboratories Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Charles River Laboratories Recent Developments and Future Plans
2.4 Shanghai Model Organisms Center Inc.
2.4.1 Shanghai Model Organisms Center Inc. Details
2.4.2 Shanghai Model Organisms Center Inc. Major Business
2.4.3 Shanghai Model Organisms Center Inc. Cancer Mouse Models Product and Solutions
2.4.4 Shanghai Model Organisms Center Inc. Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Shanghai Model Organisms Center Inc. Recent Developments and Future Plans
2.5 Envigo
2.5.1 Envigo Details
2.5.2 Envigo Major Business
2.5.3 Envigo Cancer Mouse Models Product and Solutions
2.5.4 Envigo Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Envigo Recent Developments and Future Plans
2.6 Biocytogen
2.6.1 Biocytogen Details
2.6.2 Biocytogen Major Business
2.6.3 Biocytogen Cancer Mouse Models Product and Solutions
2.6.4 Biocytogen Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Biocytogen Recent Developments and Future Plans
2.7 Genoway
2.7.1 Genoway Details
2.7.2 Genoway Major Business
2.7.3 Genoway Cancer Mouse Models Product and Solutions
2.7.4 Genoway Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Genoway Recent Developments and Future Plans
2.8 Crown Bioscience Inc. (JSR Corporation).
2.8.1 Crown Bioscience Inc. (JSR Corporation). Details
2.8.2 Crown Bioscience Inc. (JSR Corporation). Major Business
2.8.3 Crown Bioscience Inc. (JSR Corporation). Cancer Mouse Models Product and Solutions
2.8.4 Crown Bioscience Inc. (JSR Corporation). Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Crown Bioscience Inc. (JSR Corporation). Recent Developments and Future Plans
2.9 Cyagen
2.9.1 Cyagen Details
2.9.2 Cyagen Major Business
2.9.3 Cyagen Cancer Mouse Models Product and Solutions
2.9.4 Cyagen Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Cyagen Recent Developments and Future Plans
2.10 Applied stem cells
2.10.1 Applied stem cells Details
2.10.2 Applied stem cells Major Business
2.10.3 Applied stem cells Cancer Mouse Models Product and Solutions
2.10.4 Applied stem cells Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Applied stem cells Recent Developments and Future Plans
2.11 Ingenious Targeting Laboratory
2.11.1 Ingenious Targeting Laboratory Details
2.11.2 Ingenious Targeting Laboratory Major Business
2.11.3 Ingenious Targeting Laboratory Cancer Mouse Models Product and Solutions
2.11.4 Ingenious Targeting Laboratory Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Ingenious Targeting Laboratory Recent Developments and Future Plans
2.12 PolyGene - Transgenic mice model company
2.12.1 PolyGene - Transgenic mice model company Details
2.12.2 PolyGene - Transgenic mice model company Major Business
2.12.3 PolyGene - Transgenic mice model company Cancer Mouse Models Product and Solutions
2.12.4 PolyGene - Transgenic mice model company Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 PolyGene - Transgenic mice model company Recent Developments and Future Plans
2.13 Creative Biolabs
2.13.1 Creative Biolabs Details
2.13.2 Creative Biolabs Major Business
2.13.3 Creative Biolabs Cancer Mouse Models Product and Solutions
2.13.4 Creative Biolabs Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Creative Biolabs Recent Developments and Future Plans
2.14 TransCure Bioservices
2.14.1 TransCure Bioservices Details
2.14.2 TransCure Bioservices Major Business
2.14.3 TransCure Bioservices Cancer Mouse Models Product and Solutions
2.14.4 TransCure Bioservices Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 TransCure Bioservices Recent Developments and Future Plans
2.15 Champions Oncology Inc
2.15.1 Champions Oncology Inc Details
2.15.2 Champions Oncology Inc Major Business
2.15.3 Champions Oncology Inc Cancer Mouse Models Product and Solutions
2.15.4 Champions Oncology Inc Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Champions Oncology Inc Recent Developments and Future Plans
2.16 Certis Oncology
2.16.1 Certis Oncology Details
2.16.2 Certis Oncology Major Business
2.16.3 Certis Oncology Cancer Mouse Models Product and Solutions
2.16.4 Certis Oncology Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Certis Oncology Recent Developments and Future Plans
2.17 Signature
2.17.1 Signature Details
2.17.2 Signature Major Business
2.17.3 Signature Cancer Mouse Models Product and Solutions
2.17.4 Signature Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Signature Recent Developments and Future Plans
2.18 Pharmaron
2.18.1 Pharmaron Details
2.18.2 Pharmaron Major Business
2.18.3 Pharmaron Cancer Mouse Models Product and Solutions
2.18.4 Pharmaron Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Pharmaron Recent Developments and Future Plans
2.19 Laboratory Corporation of America Holdings
2.19.1 Laboratory Corporation of America Holdings Details
2.19.2 Laboratory Corporation of America Holdings Major Business
2.19.3 Laboratory Corporation of America Holdings Cancer Mouse Models Product and Solutions
2.19.4 Laboratory Corporation of America Holdings Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.20 Gempharmatech
2.20.1 Gempharmatech Details
2.20.2 Gempharmatech Major Business
2.20.3 Gempharmatech Cancer Mouse Models Product and Solutions
2.20.4 Gempharmatech Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Gempharmatech Recent Developments and Future Plans
2.21 Janvier Labs
2.21.1 Janvier Labs Details
2.21.2 Janvier Labs Major Business
2.21.3 Janvier Labs Cancer Mouse Models Product and Solutions
2.21.4 Janvier Labs Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Janvier Labs Recent Developments and Future Plans
2.22 Harbour BioMed
2.22.1 Harbour BioMed Details
2.22.2 Harbour BioMed Major Business
2.22.3 Harbour BioMed Cancer Mouse Models Product and Solutions
2.22.4 Harbour BioMed Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Harbour BioMed Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Cancer Mouse Models Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Cancer Mouse Models by Company Revenue
3.2.2 Top 3 Cancer Mouse Models Players Market Share in 2023
3.2.3 Top 6 Cancer Mouse Models Players Market Share in 2023
3.3 Cancer Mouse Models Market: Overall Company Footprint Analysis
3.3.1 Cancer Mouse Models Market: Region Footprint
3.3.2 Cancer Mouse Models Market: Company Product Type Footprint
3.3.3 Cancer Mouse Models Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Cancer Mouse Models Consumption Value and Market Share by Type (2019-2024)
4.2 Global Cancer Mouse Models Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
5.1 Global Cancer Mouse Models Consumption Value Market Share by Application (2019-2024)
5.2 Global Cancer Mouse Models Market Forecast by Application (2025-2030)

6 North America
6.1 North America Cancer Mouse Models Consumption Value by Type (2019-2030)
6.2 North America Cancer Mouse Models Consumption Value by Application (2019-2030)
6.3 North America Cancer Mouse Models Market Size by Country
6.3.1 North America Cancer Mouse Models Consumption Value by Country (2019-2030)
6.3.2 United States Cancer Mouse Models Market Size and Forecast (2019-2030)
6.3.3 Canada Cancer Mouse Models Market Size and Forecast (2019-2030)
6.3.4 Mexico Cancer Mouse Models Market Size and Forecast (2019-2030)

7 Europe
7.1 Europe Cancer Mouse Models Consumption Value by Type (2019-2030)
7.2 Europe Cancer Mouse Models Consumption Value by Application (2019-2030)
7.3 Europe Cancer Mouse Models Market Size by Country
7.3.1 Europe Cancer Mouse Models Consumption Value by Country (2019-2030)
7.3.2 Germany Cancer Mouse Models Market Size and Forecast (2019-2030)
7.3.3 France Cancer Mouse Models Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Cancer Mouse Models Market Size and Forecast (2019-2030)
7.3.5 Russia Cancer Mouse Models Market Size and Forecast (2019-2030)
7.3.6 Italy Cancer Mouse Models Market Size and Forecast (2019-2030)

8 Asia-Pacific
8.1 Asia-Pacific Cancer Mouse Models Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Cancer Mouse Models Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Cancer Mouse Models Market Size by Region
8.3.1 Asia-Pacific Cancer Mouse Models Consumption Value by Region (2019-2030)
8.3.2 China Cancer Mouse Models Market Size and Forecast (2019-2030)
8.3.3 Japan Cancer Mouse Models Market Size and Forecast (2019-2030)
8.3.4 South Korea Cancer Mouse Models Market Size and Forecast (2019-2030)
8.3.5 India Cancer Mouse Models Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Cancer Mouse Models Market Size and Forecast (2019-2030)
8.3.7 Australia Cancer Mouse Models Market Size and Forecast (2019-2030)

9 South America
9.1 South America Cancer Mouse Models Consumption Value by Type (2019-2030)
9.2 South America Cancer Mouse Models Consumption Value by Application (2019-2030)
9.3 South America Cancer Mouse Models Market Size by Country
9.3.1 South America Cancer Mouse Models Consumption Value by Country (2019-2030)
9.3.2 Brazil Cancer Mouse Models Market Size and Forecast (2019-2030)
9.3.3 Argentina Cancer Mouse Models Market Size and Forecast (2019-2030)

10 Middle East & Africa
10.1 Middle East & Africa Cancer Mouse Models Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Cancer Mouse Models Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Cancer Mouse Models Market Size by Country
10.3.1 Middle East & Africa Cancer Mouse Models Consumption Value by Country (2019-2030)
10.3.2 Turkey Cancer Mouse Models Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Cancer Mouse Models Market Size and Forecast (2019-2030)
10.3.4 UAE Cancer Mouse Models Market Size and Forecast (2019-2030)

11 Market Dynamics
11.1 Cancer Mouse Models Market Drivers
11.2 Cancer Mouse Models Market Restraints
11.3 Cancer Mouse Models Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 Cancer Mouse Models Industry Chain
12.2 Cancer Mouse Models Upstream Analysis
12.3 Cancer Mouse Models Midstream Analysis
12.4 Cancer Mouse Models Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Cancer Mouse Models Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cancer Mouse Models Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Cancer Mouse Models Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Cancer Mouse Models Consumption Value by Region (2025-2030) & (USD Million)
Table 5. The Jackson Laboratory Company Information, Head Office, and Major Competitors
Table 6. The Jackson Laboratory Major Business
Table 7. The Jackson Laboratory Cancer Mouse Models Product and Solutions
Table 8. The Jackson Laboratory Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. The Jackson Laboratory Recent Developments and Future Plans
Table 10. Taconic Biosciences Company Information, Head Office, and Major Competitors
Table 11. Taconic Biosciences Major Business
Table 12. Taconic Biosciences Cancer Mouse Models Product and Solutions
Table 13. Taconic Biosciences Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Taconic Biosciences Recent Developments and Future Plans
Table 15. Charles River Laboratories Company Information, Head Office, and Major Competitors
Table 16. Charles River Laboratories Major Business
Table 17. Charles River Laboratories Cancer Mouse Models Product and Solutions
Table 18. Charles River Laboratories Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Charles River Laboratories Recent Developments and Future Plans
Table 20. Shanghai Model Organisms Center Inc. Company Information, Head Office, and Major Competitors
Table 21. Shanghai Model Organisms Center Inc. Major Business
Table 22. Shanghai Model Organisms Center Inc. Cancer Mouse Models Product and Solutions
Table 23. Shanghai Model Organisms Center Inc. Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Shanghai Model Organisms Center Inc. Recent Developments and Future Plans
Table 25. Envigo Company Information, Head Office, and Major Competitors
Table 26. Envigo Major Business
Table 27. Envigo Cancer Mouse Models Product and Solutions
Table 28. Envigo Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Envigo Recent Developments and Future Plans
Table 30. Biocytogen Company Information, Head Office, and Major Competitors
Table 31. Biocytogen Major Business
Table 32. Biocytogen Cancer Mouse Models Product and Solutions
Table 33. Biocytogen Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Biocytogen Recent Developments and Future Plans
Table 35. Genoway Company Information, Head Office, and Major Competitors
Table 36. Genoway Major Business
Table 37. Genoway Cancer Mouse Models Product and Solutions
Table 38. Genoway Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Genoway Recent Developments and Future Plans
Table 40. Crown Bioscience Inc. (JSR Corporation). Company Information, Head Office, and Major Competitors
Table 41. Crown Bioscience Inc. (JSR Corporation). Major Business
Table 42. Crown Bioscience Inc. (JSR Corporation). Cancer Mouse Models Product and Solutions
Table 43. Crown Bioscience Inc. (JSR Corporation). Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Crown Bioscience Inc. (JSR Corporation). Recent Developments and Future Plans
Table 45. Cyagen Company Information, Head Office, and Major Competitors
Table 46. Cyagen Major Business
Table 47. Cyagen Cancer Mouse Models Product and Solutions
Table 48. Cyagen Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Cyagen Recent Developments and Future Plans
Table 50. Applied stem cells Company Information, Head Office, and Major Competitors
Table 51. Applied stem cells Major Business
Table 52. Applied stem cells Cancer Mouse Models Product and Solutions
Table 53. Applied stem cells Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Applied stem cells Recent Developments and Future Plans
Table 55. Ingenious Targeting Laboratory Company Information, Head Office, and Major Competitors
Table 56. Ingenious Targeting Laboratory Major Business
Table 57. Ingenious Targeting Laboratory Cancer Mouse Models Product and Solutions
Table 58. Ingenious Targeting Laboratory Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Ingenious Targeting Laboratory Recent Developments and Future Plans
Table 60. PolyGene - Transgenic mice model company Company Information, Head Office, and Major Competitors
Table 61. PolyGene - Transgenic mice model company Major Business
Table 62. PolyGene - Transgenic mice model company Cancer Mouse Models Product and Solutions
Table 63. PolyGene - Transgenic mice model company Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. PolyGene - Transgenic mice model company Recent Developments and Future Plans
Table 65. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 66. Creative Biolabs Major Business
Table 67. Creative Biolabs Cancer Mouse Models Product and Solutions
Table 68. Creative Biolabs Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Creative Biolabs Recent Developments and Future Plans
Table 70. TransCure Bioservices Company Information, Head Office, and Major Competitors
Table 71. TransCure Bioservices Major Business
Table 72. TransCure Bioservices Cancer Mouse Models Product and Solutions
Table 73. TransCure Bioservices Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. TransCure Bioservices Recent Developments and Future Plans
Table 75. Champions Oncology Inc Company Information, Head Office, and Major Competitors
Table 76. Champions Oncology Inc Major Business
Table 77. Champions Oncology Inc Cancer Mouse Models Product and Solutions
Table 78. Champions Oncology Inc Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Champions Oncology Inc Recent Developments and Future Plans
Table 80. Certis Oncology Company Information, Head Office, and Major Competitors
Table 81. Certis Oncology Major Business
Table 82. Certis Oncology Cancer Mouse Models Product and Solutions
Table 83. Certis Oncology Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Certis Oncology Recent Developments and Future Plans
Table 85. Signature Company Information, Head Office, and Major Competitors
Table 86. Signature Major Business
Table 87. Signature Cancer Mouse Models Product and Solutions
Table 88. Signature Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Signature Recent Developments and Future Plans
Table 90. Pharmaron Company Information, Head Office, and Major Competitors
Table 91. Pharmaron Major Business
Table 92. Pharmaron Cancer Mouse Models Product and Solutions
Table 93. Pharmaron Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Pharmaron Recent Developments and Future Plans
Table 95. Laboratory Corporation of America Holdings Company Information, Head Office, and Major Competitors
Table 96. Laboratory Corporation of America Holdings Major Business
Table 97. Laboratory Corporation of America Holdings Cancer Mouse Models Product and Solutions
Table 98. Laboratory Corporation of America Holdings Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Table 100. Gempharmatech Company Information, Head Office, and Major Competitors
Table 101. Gempharmatech Major Business
Table 102. Gempharmatech Cancer Mouse Models Product and Solutions
Table 103. Gempharmatech Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Gempharmatech Recent Developments and Future Plans
Table 105. Janvier Labs Company Information, Head Office, and Major Competitors
Table 106. Janvier Labs Major Business
Table 107. Janvier Labs Cancer Mouse Models Product and Solutions
Table 108. Janvier Labs Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. Janvier Labs Recent Developments and Future Plans
Table 110. Harbour BioMed Company Information, Head Office, and Major Competitors
Table 111. Harbour BioMed Major Business
Table 112. Harbour BioMed Cancer Mouse Models Product and Solutions
Table 113. Harbour BioMed Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. Harbour BioMed Recent Developments and Future Plans
Table 115. Global Cancer Mouse Models Revenue (USD Million) by Players (2019-2024)
Table 116. Global Cancer Mouse Models Revenue Share by Players (2019-2024)
Table 117. Breakdown of Cancer Mouse Models by Company Type (Tier 1, Tier 2, and Tier 3)
Table 118. Market Position of Players in Cancer Mouse Models, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 119. Head Office of Key Cancer Mouse Models Players
Table 120. Cancer Mouse Models Market: Company Product Type Footprint
Table 121. Cancer Mouse Models Market: Company Product Application Footprint
Table 122. Cancer Mouse Models New Market Entrants and Barriers to Market Entry
Table 123. Cancer Mouse Models Mergers, Acquisition, Agreements, and Collaborations
Table 124. Global Cancer Mouse Models Consumption Value (USD Million) by Type (2019-2024)
Table 125. Global Cancer Mouse Models Consumption Value Share by Type (2019-2024)
Table 126. Global Cancer Mouse Models Consumption Value Forecast by Type (2025-2030)
Table 127. Global Cancer Mouse Models Consumption Value by Application (2019-2024)
Table 128. Global Cancer Mouse Models Consumption Value Forecast by Application (2025-2030)
Table 129. North America Cancer Mouse Models Consumption Value by Type (2019-2024) & (USD Million)
Table 130. North America Cancer Mouse Models Consumption Value by Type (2025-2030) & (USD Million)
Table 131. North America Cancer Mouse Models Consumption Value by Application (2019-2024) & (USD Million)
Table 132. North America Cancer Mouse Models Consumption Value by Application (2025-2030) & (USD Million)
Table 133. North America Cancer Mouse Models Consumption Value by Country (2019-2024) & (USD Million)
Table 134. North America Cancer Mouse Models Consumption Value by Country (2025-2030) & (USD Million)
Table 135. Europe Cancer Mouse Models Consumption Value by Type (2019-2024) & (USD Million)
Table 136. Europe Cancer Mouse Models Consumption Value by Type (2025-2030) & (USD Million)
Table 137. Europe Cancer Mouse Models Consumption Value by Application (2019-2024) & (USD Million)
Table 138. Europe Cancer Mouse Models Consumption Value by Application (2025-2030) & (USD Million)
Table 139. Europe Cancer Mouse Models Consumption Value by Country (2019-2024) & (USD Million)
Table 140. Europe Cancer Mouse Models Consumption Value by Country (2025-2030) & (USD Million)
Table 141. Asia-Pacific Cancer Mouse Models Consumption Value by Type (2019-2024) & (USD Million)
Table 142. Asia-Pacific Cancer Mouse Models Consumption Value by Type (2025-2030) & (USD Million)
Table 143. Asia-Pacific Cancer Mouse Models Consumption Value by Application (2019-2024) & (USD Million)
Table 144. Asia-Pacific Cancer Mouse Models Consumption Value by Application (2025-2030) & (USD Million)
Table 145. Asia-Pacific Cancer Mouse Models Consumption Value by Region (2019-2024) & (USD Million)
Table 146. Asia-Pacific Cancer Mouse Models Consumption Value by Region (2025-2030) & (USD Million)
Table 147. South America Cancer Mouse Models Consumption Value by Type (2019-2024) & (USD Million)
Table 148. South America Cancer Mouse Models Consumption Value by Type (2025-2030) & (USD Million)
Table 149. South America Cancer Mouse Models Consumption Value by Application (2019-2024) & (USD Million)
Table 150. South America Cancer Mouse Models Consumption Value by Application (2025-2030) & (USD Million)
Table 151. South America Cancer Mouse Models Consumption Value by Country (2019-2024) & (USD Million)
Table 152. South America Cancer Mouse Models Consumption Value by Country (2025-2030) & (USD Million)
Table 153. Middle East & Africa Cancer Mouse Models Consumption Value by Type (2019-2024) & (USD Million)
Table 154. Middle East & Africa Cancer Mouse Models Consumption Value by Type (2025-2030) & (USD Million)
Table 155. Middle East & Africa Cancer Mouse Models Consumption Value by Application (2019-2024) & (USD Million)
Table 156. Middle East & Africa Cancer Mouse Models Consumption Value by Application (2025-2030) & (USD Million)
Table 157. Middle East & Africa Cancer Mouse Models Consumption Value by Country (2019-2024) & (USD Million)
Table 158. Middle East & Africa Cancer Mouse Models Consumption Value by Country (2025-2030) & (USD Million)
Table 159. Cancer Mouse Models Raw Material
Table 160. Key Suppliers of Cancer Mouse Models Raw Materials
List of Figures
Figure 1. Cancer Mouse Models Picture
Figure 2. Global Cancer Mouse Models Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cancer Mouse Models Consumption Value Market Share by Type in 2023
Figure 4. Humanized Immune System Mouse Models
Figure 5. Syngeneic Tumor Mouse Models
Figure 6. Immunodeficient Mouse Models
Figure 7. NOG Mouse Models
Figure 8. Spontaneous Tumor Mouse Models
Figure 9. Others
Figure 10. Global Cancer Mouse Models Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 11. Cancer Mouse Models Consumption Value Market Share by Application in 2023
Figure 12. Contract Research Organizations Picture
Figure 13. Pharma and Biopharma Companies Picture
Figure 14. Academic and Research Institutes Picture
Figure 15. Global Cancer Mouse Models Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Cancer Mouse Models Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Market Cancer Mouse Models Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 18. Global Cancer Mouse Models Consumption Value Market Share by Region (2019-2030)
Figure 19. Global Cancer Mouse Models Consumption Value Market Share by Region in 2023
Figure 20. North America Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 21. Europe Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 22. Asia-Pacific Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 23. South America Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 24. Middle East and Africa Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 25. Global Cancer Mouse Models Revenue Share by Players in 2023
Figure 26. Cancer Mouse Models Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 27. Global Top 3 Players Cancer Mouse Models Market Share in 2023
Figure 28. Global Top 6 Players Cancer Mouse Models Market Share in 2023
Figure 29. Global Cancer Mouse Models Consumption Value Share by Type (2019-2024)
Figure 30. Global Cancer Mouse Models Market Share Forecast by Type (2025-2030)
Figure 31. Global Cancer Mouse Models Consumption Value Share by Application (2019-2024)
Figure 32. Global Cancer Mouse Models Market Share Forecast by Application (2025-2030)
Figure 33. North America Cancer Mouse Models Consumption Value Market Share by Type (2019-2030)
Figure 34. North America Cancer Mouse Models Consumption Value Market Share by Application (2019-2030)
Figure 35. North America Cancer Mouse Models Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe Cancer Mouse Models Consumption Value Market Share by Type (2019-2030)
Figure 40. Europe Cancer Mouse Models Consumption Value Market Share by Application (2019-2030)
Figure 41. Europe Cancer Mouse Models Consumption Value Market Share by Country (2019-2030)
Figure 42. Germany Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 43. France Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 44. United Kingdom Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 45. Russia Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 46. Italy Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 47. Asia-Pacific Cancer Mouse Models Consumption Value Market Share by Type (2019-2030)
Figure 48. Asia-Pacific Cancer Mouse Models Consumption Value Market Share by Application (2019-2030)
Figure 49. Asia-Pacific Cancer Mouse Models Consumption Value Market Share by Region (2019-2030)
Figure 50. China Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 51. Japan Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 52. South Korea Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 53. India Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 54. Southeast Asia Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 55. Australia Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 56. South America Cancer Mouse Models Consumption Value Market Share by Type (2019-2030)
Figure 57. South America Cancer Mouse Models Consumption Value Market Share by Application (2019-2030)
Figure 58. South America Cancer Mouse Models Consumption Value Market Share by Country (2019-2030)
Figure 59. Brazil Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 60. Argentina Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 61. Middle East and Africa Cancer Mouse Models Consumption Value Market Share by Type (2019-2030)
Figure 62. Middle East and Africa Cancer Mouse Models Consumption Value Market Share by Application (2019-2030)
Figure 63. Middle East and Africa Cancer Mouse Models Consumption Value Market Share by Country (2019-2030)
Figure 64. Turkey Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 65. Saudi Arabia Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 66. UAE Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 67. Cancer Mouse Models Market Drivers
Figure 68. Cancer Mouse Models Market Restraints
Figure 69. Cancer Mouse Models Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Cancer Mouse Models in 2023
Figure 72. Manufacturing Process Analysis of Cancer Mouse Models
Figure 73. Cancer Mouse Models Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

The Jackson Laboratory
Taconic Biosciences
Charles River Laboratories
Shanghai Model Organisms Center Inc.
Envigo
Biocytogen
Genoway
Crown Bioscience Inc. (JSR Corporation).
Cyagen
Applied stem cells
Ingenious Targeting Laboratory
PolyGene - Transgenic mice model company
Creative Biolabs
TransCure Bioservices
Champions Oncology Inc
Certis Oncology
Signature
Pharmaron
Laboratory Corporation of America Holdings
Gempharmatech
Janvier Labs
Harbour BioMed
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Cancer Mouse Models Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cancer Mouse Models Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 144

Published Date: 02 Jan 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

According to our (Global Info Research) latest study, the global Cancer Mouse Models market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the Cancer Mouse Models industry chain, the market status of Contract Research Organizations (Humanized Immune System Mouse Models, Syngeneic Tumor Mouse Models), Pharma and Biopharma Companies (Humanized Immune System Mouse Models, Syngeneic Tumor Mouse Models), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cancer Mouse Models.

Regionally, the report analyzes the Cancer Mouse Models markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cancer Mouse Models market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Cancer Mouse Models market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cancer Mouse Models industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Humanized Immune System Mouse Models, Syngeneic Tumor Mouse Models).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cancer Mouse Models market.

Regional Analysis: The report involves examining the Cancer Mouse Models market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cancer Mouse Models market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Cancer Mouse Models:
Company Analysis: Report covers individual Cancer Mouse Models players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cancer Mouse Models This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Contract Research Organizations, Pharma and Biopharma Companies).

Technology Analysis: Report covers specific technologies relevant to Cancer Mouse Models. It assesses the current state, advancements, and potential future developments in Cancer Mouse Models areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cancer Mouse Models market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Cancer Mouse Models market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Humanized Immune System Mouse Models
Syngeneic Tumor Mouse Models
Immunodeficient Mouse Models
NOG Mouse Models
Spontaneous Tumor Mouse Models
Others

Market segment by Application
Contract Research Organizations
Pharma and Biopharma Companies
Academic and Research Institutes

Market segment by players, this report covers
The Jackson Laboratory
Taconic Biosciences
Charles River Laboratories
Shanghai Model Organisms Center Inc.
Envigo
Biocytogen
Genoway
Crown Bioscience Inc. (JSR Corporation).
Cyagen
Applied stem cells
Ingenious Targeting Laboratory
PolyGene - Transgenic mice model company
Creative Biolabs
TransCure Bioservices
Champions Oncology Inc
Certis Oncology
Signature
Pharmaron
Laboratory Corporation of America Holdings
Gempharmatech
Janvier Labs
Harbour BioMed

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cancer Mouse Models product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cancer Mouse Models, with revenue, gross margin and global market share of Cancer Mouse Models from 2019 to 2024.
Chapter 3, the Cancer Mouse Models competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cancer Mouse Models market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Mouse Models.
Chapter 13, to describe Cancer Mouse Models research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Cancer Mouse Models
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cancer Mouse Models by Type
1.3.1 Overview: Global Cancer Mouse Models Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Cancer Mouse Models Consumption Value Market Share by Type in 2023
1.3.3 Humanized Immune System Mouse Models
1.3.4 Syngeneic Tumor Mouse Models
1.3.5 Immunodeficient Mouse Models
1.3.6 NOG Mouse Models
1.3.7 Spontaneous Tumor Mouse Models
1.3.8 Others
1.4 Global Cancer Mouse Models Market by Application
1.4.1 Overview: Global Cancer Mouse Models Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Contract Research Organizations
1.4.3 Pharma and Biopharma Companies
1.4.4 Academic and Research Institutes
1.5 Global Cancer Mouse Models Market Size & Forecast
1.6 Global Cancer Mouse Models Market Size and Forecast by Region
1.6.1 Global Cancer Mouse Models Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Cancer Mouse Models Market Size by Region, (2019-2030)
1.6.3 North America Cancer Mouse Models Market Size and Prospect (2019-2030)
1.6.4 Europe Cancer Mouse Models Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Cancer Mouse Models Market Size and Prospect (2019-2030)
1.6.6 South America Cancer Mouse Models Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Cancer Mouse Models Market Size and Prospect (2019-2030)

2 Company Profiles
2.1 The Jackson Laboratory
2.1.1 The Jackson Laboratory Details
2.1.2 The Jackson Laboratory Major Business
2.1.3 The Jackson Laboratory Cancer Mouse Models Product and Solutions
2.1.4 The Jackson Laboratory Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 The Jackson Laboratory Recent Developments and Future Plans
2.2 Taconic Biosciences
2.2.1 Taconic Biosciences Details
2.2.2 Taconic Biosciences Major Business
2.2.3 Taconic Biosciences Cancer Mouse Models Product and Solutions
2.2.4 Taconic Biosciences Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Taconic Biosciences Recent Developments and Future Plans
2.3 Charles River Laboratories
2.3.1 Charles River Laboratories Details
2.3.2 Charles River Laboratories Major Business
2.3.3 Charles River Laboratories Cancer Mouse Models Product and Solutions
2.3.4 Charles River Laboratories Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Charles River Laboratories Recent Developments and Future Plans
2.4 Shanghai Model Organisms Center Inc.
2.4.1 Shanghai Model Organisms Center Inc. Details
2.4.2 Shanghai Model Organisms Center Inc. Major Business
2.4.3 Shanghai Model Organisms Center Inc. Cancer Mouse Models Product and Solutions
2.4.4 Shanghai Model Organisms Center Inc. Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Shanghai Model Organisms Center Inc. Recent Developments and Future Plans
2.5 Envigo
2.5.1 Envigo Details
2.5.2 Envigo Major Business
2.5.3 Envigo Cancer Mouse Models Product and Solutions
2.5.4 Envigo Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Envigo Recent Developments and Future Plans
2.6 Biocytogen
2.6.1 Biocytogen Details
2.6.2 Biocytogen Major Business
2.6.3 Biocytogen Cancer Mouse Models Product and Solutions
2.6.4 Biocytogen Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Biocytogen Recent Developments and Future Plans
2.7 Genoway
2.7.1 Genoway Details
2.7.2 Genoway Major Business
2.7.3 Genoway Cancer Mouse Models Product and Solutions
2.7.4 Genoway Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Genoway Recent Developments and Future Plans
2.8 Crown Bioscience Inc. (JSR Corporation).
2.8.1 Crown Bioscience Inc. (JSR Corporation). Details
2.8.2 Crown Bioscience Inc. (JSR Corporation). Major Business
2.8.3 Crown Bioscience Inc. (JSR Corporation). Cancer Mouse Models Product and Solutions
2.8.4 Crown Bioscience Inc. (JSR Corporation). Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Crown Bioscience Inc. (JSR Corporation). Recent Developments and Future Plans
2.9 Cyagen
2.9.1 Cyagen Details
2.9.2 Cyagen Major Business
2.9.3 Cyagen Cancer Mouse Models Product and Solutions
2.9.4 Cyagen Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Cyagen Recent Developments and Future Plans
2.10 Applied stem cells
2.10.1 Applied stem cells Details
2.10.2 Applied stem cells Major Business
2.10.3 Applied stem cells Cancer Mouse Models Product and Solutions
2.10.4 Applied stem cells Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Applied stem cells Recent Developments and Future Plans
2.11 Ingenious Targeting Laboratory
2.11.1 Ingenious Targeting Laboratory Details
2.11.2 Ingenious Targeting Laboratory Major Business
2.11.3 Ingenious Targeting Laboratory Cancer Mouse Models Product and Solutions
2.11.4 Ingenious Targeting Laboratory Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Ingenious Targeting Laboratory Recent Developments and Future Plans
2.12 PolyGene - Transgenic mice model company
2.12.1 PolyGene - Transgenic mice model company Details
2.12.2 PolyGene - Transgenic mice model company Major Business
2.12.3 PolyGene - Transgenic mice model company Cancer Mouse Models Product and Solutions
2.12.4 PolyGene - Transgenic mice model company Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 PolyGene - Transgenic mice model company Recent Developments and Future Plans
2.13 Creative Biolabs
2.13.1 Creative Biolabs Details
2.13.2 Creative Biolabs Major Business
2.13.3 Creative Biolabs Cancer Mouse Models Product and Solutions
2.13.4 Creative Biolabs Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Creative Biolabs Recent Developments and Future Plans
2.14 TransCure Bioservices
2.14.1 TransCure Bioservices Details
2.14.2 TransCure Bioservices Major Business
2.14.3 TransCure Bioservices Cancer Mouse Models Product and Solutions
2.14.4 TransCure Bioservices Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 TransCure Bioservices Recent Developments and Future Plans
2.15 Champions Oncology Inc
2.15.1 Champions Oncology Inc Details
2.15.2 Champions Oncology Inc Major Business
2.15.3 Champions Oncology Inc Cancer Mouse Models Product and Solutions
2.15.4 Champions Oncology Inc Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Champions Oncology Inc Recent Developments and Future Plans
2.16 Certis Oncology
2.16.1 Certis Oncology Details
2.16.2 Certis Oncology Major Business
2.16.3 Certis Oncology Cancer Mouse Models Product and Solutions
2.16.4 Certis Oncology Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Certis Oncology Recent Developments and Future Plans
2.17 Signature
2.17.1 Signature Details
2.17.2 Signature Major Business
2.17.3 Signature Cancer Mouse Models Product and Solutions
2.17.4 Signature Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Signature Recent Developments and Future Plans
2.18 Pharmaron
2.18.1 Pharmaron Details
2.18.2 Pharmaron Major Business
2.18.3 Pharmaron Cancer Mouse Models Product and Solutions
2.18.4 Pharmaron Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Pharmaron Recent Developments and Future Plans
2.19 Laboratory Corporation of America Holdings
2.19.1 Laboratory Corporation of America Holdings Details
2.19.2 Laboratory Corporation of America Holdings Major Business
2.19.3 Laboratory Corporation of America Holdings Cancer Mouse Models Product and Solutions
2.19.4 Laboratory Corporation of America Holdings Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.20 Gempharmatech
2.20.1 Gempharmatech Details
2.20.2 Gempharmatech Major Business
2.20.3 Gempharmatech Cancer Mouse Models Product and Solutions
2.20.4 Gempharmatech Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Gempharmatech Recent Developments and Future Plans
2.21 Janvier Labs
2.21.1 Janvier Labs Details
2.21.2 Janvier Labs Major Business
2.21.3 Janvier Labs Cancer Mouse Models Product and Solutions
2.21.4 Janvier Labs Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Janvier Labs Recent Developments and Future Plans
2.22 Harbour BioMed
2.22.1 Harbour BioMed Details
2.22.2 Harbour BioMed Major Business
2.22.3 Harbour BioMed Cancer Mouse Models Product and Solutions
2.22.4 Harbour BioMed Cancer Mouse Models Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Harbour BioMed Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Cancer Mouse Models Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Cancer Mouse Models by Company Revenue
3.2.2 Top 3 Cancer Mouse Models Players Market Share in 2023
3.2.3 Top 6 Cancer Mouse Models Players Market Share in 2023
3.3 Cancer Mouse Models Market: Overall Company Footprint Analysis
3.3.1 Cancer Mouse Models Market: Region Footprint
3.3.2 Cancer Mouse Models Market: Company Product Type Footprint
3.3.3 Cancer Mouse Models Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Cancer Mouse Models Consumption Value and Market Share by Type (2019-2024)
4.2 Global Cancer Mouse Models Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
5.1 Global Cancer Mouse Models Consumption Value Market Share by Application (2019-2024)
5.2 Global Cancer Mouse Models Market Forecast by Application (2025-2030)

6 North America
6.1 North America Cancer Mouse Models Consumption Value by Type (2019-2030)
6.2 North America Cancer Mouse Models Consumption Value by Application (2019-2030)
6.3 North America Cancer Mouse Models Market Size by Country
6.3.1 North America Cancer Mouse Models Consumption Value by Country (2019-2030)
6.3.2 United States Cancer Mouse Models Market Size and Forecast (2019-2030)
6.3.3 Canada Cancer Mouse Models Market Size and Forecast (2019-2030)
6.3.4 Mexico Cancer Mouse Models Market Size and Forecast (2019-2030)

7 Europe
7.1 Europe Cancer Mouse Models Consumption Value by Type (2019-2030)
7.2 Europe Cancer Mouse Models Consumption Value by Application (2019-2030)
7.3 Europe Cancer Mouse Models Market Size by Country
7.3.1 Europe Cancer Mouse Models Consumption Value by Country (2019-2030)
7.3.2 Germany Cancer Mouse Models Market Size and Forecast (2019-2030)
7.3.3 France Cancer Mouse Models Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Cancer Mouse Models Market Size and Forecast (2019-2030)
7.3.5 Russia Cancer Mouse Models Market Size and Forecast (2019-2030)
7.3.6 Italy Cancer Mouse Models Market Size and Forecast (2019-2030)

8 Asia-Pacific
8.1 Asia-Pacific Cancer Mouse Models Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Cancer Mouse Models Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Cancer Mouse Models Market Size by Region
8.3.1 Asia-Pacific Cancer Mouse Models Consumption Value by Region (2019-2030)
8.3.2 China Cancer Mouse Models Market Size and Forecast (2019-2030)
8.3.3 Japan Cancer Mouse Models Market Size and Forecast (2019-2030)
8.3.4 South Korea Cancer Mouse Models Market Size and Forecast (2019-2030)
8.3.5 India Cancer Mouse Models Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Cancer Mouse Models Market Size and Forecast (2019-2030)
8.3.7 Australia Cancer Mouse Models Market Size and Forecast (2019-2030)

9 South America
9.1 South America Cancer Mouse Models Consumption Value by Type (2019-2030)
9.2 South America Cancer Mouse Models Consumption Value by Application (2019-2030)
9.3 South America Cancer Mouse Models Market Size by Country
9.3.1 South America Cancer Mouse Models Consumption Value by Country (2019-2030)
9.3.2 Brazil Cancer Mouse Models Market Size and Forecast (2019-2030)
9.3.3 Argentina Cancer Mouse Models Market Size and Forecast (2019-2030)

10 Middle East & Africa
10.1 Middle East & Africa Cancer Mouse Models Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Cancer Mouse Models Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Cancer Mouse Models Market Size by Country
10.3.1 Middle East & Africa Cancer Mouse Models Consumption Value by Country (2019-2030)
10.3.2 Turkey Cancer Mouse Models Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Cancer Mouse Models Market Size and Forecast (2019-2030)
10.3.4 UAE Cancer Mouse Models Market Size and Forecast (2019-2030)

11 Market Dynamics
11.1 Cancer Mouse Models Market Drivers
11.2 Cancer Mouse Models Market Restraints
11.3 Cancer Mouse Models Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 Cancer Mouse Models Industry Chain
12.2 Cancer Mouse Models Upstream Analysis
12.3 Cancer Mouse Models Midstream Analysis
12.4 Cancer Mouse Models Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Cancer Mouse Models Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cancer Mouse Models Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Cancer Mouse Models Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Cancer Mouse Models Consumption Value by Region (2025-2030) & (USD Million)
Table 5. The Jackson Laboratory Company Information, Head Office, and Major Competitors
Table 6. The Jackson Laboratory Major Business
Table 7. The Jackson Laboratory Cancer Mouse Models Product and Solutions
Table 8. The Jackson Laboratory Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. The Jackson Laboratory Recent Developments and Future Plans
Table 10. Taconic Biosciences Company Information, Head Office, and Major Competitors
Table 11. Taconic Biosciences Major Business
Table 12. Taconic Biosciences Cancer Mouse Models Product and Solutions
Table 13. Taconic Biosciences Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Taconic Biosciences Recent Developments and Future Plans
Table 15. Charles River Laboratories Company Information, Head Office, and Major Competitors
Table 16. Charles River Laboratories Major Business
Table 17. Charles River Laboratories Cancer Mouse Models Product and Solutions
Table 18. Charles River Laboratories Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Charles River Laboratories Recent Developments and Future Plans
Table 20. Shanghai Model Organisms Center Inc. Company Information, Head Office, and Major Competitors
Table 21. Shanghai Model Organisms Center Inc. Major Business
Table 22. Shanghai Model Organisms Center Inc. Cancer Mouse Models Product and Solutions
Table 23. Shanghai Model Organisms Center Inc. Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Shanghai Model Organisms Center Inc. Recent Developments and Future Plans
Table 25. Envigo Company Information, Head Office, and Major Competitors
Table 26. Envigo Major Business
Table 27. Envigo Cancer Mouse Models Product and Solutions
Table 28. Envigo Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Envigo Recent Developments and Future Plans
Table 30. Biocytogen Company Information, Head Office, and Major Competitors
Table 31. Biocytogen Major Business
Table 32. Biocytogen Cancer Mouse Models Product and Solutions
Table 33. Biocytogen Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Biocytogen Recent Developments and Future Plans
Table 35. Genoway Company Information, Head Office, and Major Competitors
Table 36. Genoway Major Business
Table 37. Genoway Cancer Mouse Models Product and Solutions
Table 38. Genoway Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Genoway Recent Developments and Future Plans
Table 40. Crown Bioscience Inc. (JSR Corporation). Company Information, Head Office, and Major Competitors
Table 41. Crown Bioscience Inc. (JSR Corporation). Major Business
Table 42. Crown Bioscience Inc. (JSR Corporation). Cancer Mouse Models Product and Solutions
Table 43. Crown Bioscience Inc. (JSR Corporation). Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Crown Bioscience Inc. (JSR Corporation). Recent Developments and Future Plans
Table 45. Cyagen Company Information, Head Office, and Major Competitors
Table 46. Cyagen Major Business
Table 47. Cyagen Cancer Mouse Models Product and Solutions
Table 48. Cyagen Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Cyagen Recent Developments and Future Plans
Table 50. Applied stem cells Company Information, Head Office, and Major Competitors
Table 51. Applied stem cells Major Business
Table 52. Applied stem cells Cancer Mouse Models Product and Solutions
Table 53. Applied stem cells Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Applied stem cells Recent Developments and Future Plans
Table 55. Ingenious Targeting Laboratory Company Information, Head Office, and Major Competitors
Table 56. Ingenious Targeting Laboratory Major Business
Table 57. Ingenious Targeting Laboratory Cancer Mouse Models Product and Solutions
Table 58. Ingenious Targeting Laboratory Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Ingenious Targeting Laboratory Recent Developments and Future Plans
Table 60. PolyGene - Transgenic mice model company Company Information, Head Office, and Major Competitors
Table 61. PolyGene - Transgenic mice model company Major Business
Table 62. PolyGene - Transgenic mice model company Cancer Mouse Models Product and Solutions
Table 63. PolyGene - Transgenic mice model company Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. PolyGene - Transgenic mice model company Recent Developments and Future Plans
Table 65. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 66. Creative Biolabs Major Business
Table 67. Creative Biolabs Cancer Mouse Models Product and Solutions
Table 68. Creative Biolabs Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Creative Biolabs Recent Developments and Future Plans
Table 70. TransCure Bioservices Company Information, Head Office, and Major Competitors
Table 71. TransCure Bioservices Major Business
Table 72. TransCure Bioservices Cancer Mouse Models Product and Solutions
Table 73. TransCure Bioservices Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. TransCure Bioservices Recent Developments and Future Plans
Table 75. Champions Oncology Inc Company Information, Head Office, and Major Competitors
Table 76. Champions Oncology Inc Major Business
Table 77. Champions Oncology Inc Cancer Mouse Models Product and Solutions
Table 78. Champions Oncology Inc Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Champions Oncology Inc Recent Developments and Future Plans
Table 80. Certis Oncology Company Information, Head Office, and Major Competitors
Table 81. Certis Oncology Major Business
Table 82. Certis Oncology Cancer Mouse Models Product and Solutions
Table 83. Certis Oncology Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Certis Oncology Recent Developments and Future Plans
Table 85. Signature Company Information, Head Office, and Major Competitors
Table 86. Signature Major Business
Table 87. Signature Cancer Mouse Models Product and Solutions
Table 88. Signature Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Signature Recent Developments and Future Plans
Table 90. Pharmaron Company Information, Head Office, and Major Competitors
Table 91. Pharmaron Major Business
Table 92. Pharmaron Cancer Mouse Models Product and Solutions
Table 93. Pharmaron Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Pharmaron Recent Developments and Future Plans
Table 95. Laboratory Corporation of America Holdings Company Information, Head Office, and Major Competitors
Table 96. Laboratory Corporation of America Holdings Major Business
Table 97. Laboratory Corporation of America Holdings Cancer Mouse Models Product and Solutions
Table 98. Laboratory Corporation of America Holdings Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Table 100. Gempharmatech Company Information, Head Office, and Major Competitors
Table 101. Gempharmatech Major Business
Table 102. Gempharmatech Cancer Mouse Models Product and Solutions
Table 103. Gempharmatech Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Gempharmatech Recent Developments and Future Plans
Table 105. Janvier Labs Company Information, Head Office, and Major Competitors
Table 106. Janvier Labs Major Business
Table 107. Janvier Labs Cancer Mouse Models Product and Solutions
Table 108. Janvier Labs Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. Janvier Labs Recent Developments and Future Plans
Table 110. Harbour BioMed Company Information, Head Office, and Major Competitors
Table 111. Harbour BioMed Major Business
Table 112. Harbour BioMed Cancer Mouse Models Product and Solutions
Table 113. Harbour BioMed Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. Harbour BioMed Recent Developments and Future Plans
Table 115. Global Cancer Mouse Models Revenue (USD Million) by Players (2019-2024)
Table 116. Global Cancer Mouse Models Revenue Share by Players (2019-2024)
Table 117. Breakdown of Cancer Mouse Models by Company Type (Tier 1, Tier 2, and Tier 3)
Table 118. Market Position of Players in Cancer Mouse Models, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 119. Head Office of Key Cancer Mouse Models Players
Table 120. Cancer Mouse Models Market: Company Product Type Footprint
Table 121. Cancer Mouse Models Market: Company Product Application Footprint
Table 122. Cancer Mouse Models New Market Entrants and Barriers to Market Entry
Table 123. Cancer Mouse Models Mergers, Acquisition, Agreements, and Collaborations
Table 124. Global Cancer Mouse Models Consumption Value (USD Million) by Type (2019-2024)
Table 125. Global Cancer Mouse Models Consumption Value Share by Type (2019-2024)
Table 126. Global Cancer Mouse Models Consumption Value Forecast by Type (2025-2030)
Table 127. Global Cancer Mouse Models Consumption Value by Application (2019-2024)
Table 128. Global Cancer Mouse Models Consumption Value Forecast by Application (2025-2030)
Table 129. North America Cancer Mouse Models Consumption Value by Type (2019-2024) & (USD Million)
Table 130. North America Cancer Mouse Models Consumption Value by Type (2025-2030) & (USD Million)
Table 131. North America Cancer Mouse Models Consumption Value by Application (2019-2024) & (USD Million)
Table 132. North America Cancer Mouse Models Consumption Value by Application (2025-2030) & (USD Million)
Table 133. North America Cancer Mouse Models Consumption Value by Country (2019-2024) & (USD Million)
Table 134. North America Cancer Mouse Models Consumption Value by Country (2025-2030) & (USD Million)
Table 135. Europe Cancer Mouse Models Consumption Value by Type (2019-2024) & (USD Million)
Table 136. Europe Cancer Mouse Models Consumption Value by Type (2025-2030) & (USD Million)
Table 137. Europe Cancer Mouse Models Consumption Value by Application (2019-2024) & (USD Million)
Table 138. Europe Cancer Mouse Models Consumption Value by Application (2025-2030) & (USD Million)
Table 139. Europe Cancer Mouse Models Consumption Value by Country (2019-2024) & (USD Million)
Table 140. Europe Cancer Mouse Models Consumption Value by Country (2025-2030) & (USD Million)
Table 141. Asia-Pacific Cancer Mouse Models Consumption Value by Type (2019-2024) & (USD Million)
Table 142. Asia-Pacific Cancer Mouse Models Consumption Value by Type (2025-2030) & (USD Million)
Table 143. Asia-Pacific Cancer Mouse Models Consumption Value by Application (2019-2024) & (USD Million)
Table 144. Asia-Pacific Cancer Mouse Models Consumption Value by Application (2025-2030) & (USD Million)
Table 145. Asia-Pacific Cancer Mouse Models Consumption Value by Region (2019-2024) & (USD Million)
Table 146. Asia-Pacific Cancer Mouse Models Consumption Value by Region (2025-2030) & (USD Million)
Table 147. South America Cancer Mouse Models Consumption Value by Type (2019-2024) & (USD Million)
Table 148. South America Cancer Mouse Models Consumption Value by Type (2025-2030) & (USD Million)
Table 149. South America Cancer Mouse Models Consumption Value by Application (2019-2024) & (USD Million)
Table 150. South America Cancer Mouse Models Consumption Value by Application (2025-2030) & (USD Million)
Table 151. South America Cancer Mouse Models Consumption Value by Country (2019-2024) & (USD Million)
Table 152. South America Cancer Mouse Models Consumption Value by Country (2025-2030) & (USD Million)
Table 153. Middle East & Africa Cancer Mouse Models Consumption Value by Type (2019-2024) & (USD Million)
Table 154. Middle East & Africa Cancer Mouse Models Consumption Value by Type (2025-2030) & (USD Million)
Table 155. Middle East & Africa Cancer Mouse Models Consumption Value by Application (2019-2024) & (USD Million)
Table 156. Middle East & Africa Cancer Mouse Models Consumption Value by Application (2025-2030) & (USD Million)
Table 157. Middle East & Africa Cancer Mouse Models Consumption Value by Country (2019-2024) & (USD Million)
Table 158. Middle East & Africa Cancer Mouse Models Consumption Value by Country (2025-2030) & (USD Million)
Table 159. Cancer Mouse Models Raw Material
Table 160. Key Suppliers of Cancer Mouse Models Raw Materials
List of Figures
Figure 1. Cancer Mouse Models Picture
Figure 2. Global Cancer Mouse Models Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cancer Mouse Models Consumption Value Market Share by Type in 2023
Figure 4. Humanized Immune System Mouse Models
Figure 5. Syngeneic Tumor Mouse Models
Figure 6. Immunodeficient Mouse Models
Figure 7. NOG Mouse Models
Figure 8. Spontaneous Tumor Mouse Models
Figure 9. Others
Figure 10. Global Cancer Mouse Models Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 11. Cancer Mouse Models Consumption Value Market Share by Application in 2023
Figure 12. Contract Research Organizations Picture
Figure 13. Pharma and Biopharma Companies Picture
Figure 14. Academic and Research Institutes Picture
Figure 15. Global Cancer Mouse Models Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Cancer Mouse Models Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Market Cancer Mouse Models Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 18. Global Cancer Mouse Models Consumption Value Market Share by Region (2019-2030)
Figure 19. Global Cancer Mouse Models Consumption Value Market Share by Region in 2023
Figure 20. North America Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 21. Europe Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 22. Asia-Pacific Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 23. South America Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 24. Middle East and Africa Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 25. Global Cancer Mouse Models Revenue Share by Players in 2023
Figure 26. Cancer Mouse Models Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 27. Global Top 3 Players Cancer Mouse Models Market Share in 2023
Figure 28. Global Top 6 Players Cancer Mouse Models Market Share in 2023
Figure 29. Global Cancer Mouse Models Consumption Value Share by Type (2019-2024)
Figure 30. Global Cancer Mouse Models Market Share Forecast by Type (2025-2030)
Figure 31. Global Cancer Mouse Models Consumption Value Share by Application (2019-2024)
Figure 32. Global Cancer Mouse Models Market Share Forecast by Application (2025-2030)
Figure 33. North America Cancer Mouse Models Consumption Value Market Share by Type (2019-2030)
Figure 34. North America Cancer Mouse Models Consumption Value Market Share by Application (2019-2030)
Figure 35. North America Cancer Mouse Models Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe Cancer Mouse Models Consumption Value Market Share by Type (2019-2030)
Figure 40. Europe Cancer Mouse Models Consumption Value Market Share by Application (2019-2030)
Figure 41. Europe Cancer Mouse Models Consumption Value Market Share by Country (2019-2030)
Figure 42. Germany Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 43. France Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 44. United Kingdom Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 45. Russia Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 46. Italy Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 47. Asia-Pacific Cancer Mouse Models Consumption Value Market Share by Type (2019-2030)
Figure 48. Asia-Pacific Cancer Mouse Models Consumption Value Market Share by Application (2019-2030)
Figure 49. Asia-Pacific Cancer Mouse Models Consumption Value Market Share by Region (2019-2030)
Figure 50. China Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 51. Japan Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 52. South Korea Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 53. India Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 54. Southeast Asia Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 55. Australia Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 56. South America Cancer Mouse Models Consumption Value Market Share by Type (2019-2030)
Figure 57. South America Cancer Mouse Models Consumption Value Market Share by Application (2019-2030)
Figure 58. South America Cancer Mouse Models Consumption Value Market Share by Country (2019-2030)
Figure 59. Brazil Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 60. Argentina Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 61. Middle East and Africa Cancer Mouse Models Consumption Value Market Share by Type (2019-2030)
Figure 62. Middle East and Africa Cancer Mouse Models Consumption Value Market Share by Application (2019-2030)
Figure 63. Middle East and Africa Cancer Mouse Models Consumption Value Market Share by Country (2019-2030)
Figure 64. Turkey Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 65. Saudi Arabia Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 66. UAE Cancer Mouse Models Consumption Value (2019-2030) & (USD Million)
Figure 67. Cancer Mouse Models Market Drivers
Figure 68. Cancer Mouse Models Market Restraints
Figure 69. Cancer Mouse Models Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Cancer Mouse Models in 2023
Figure 72. Manufacturing Process Analysis of Cancer Mouse Models
Figure 73. Cancer Mouse Models Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

The Jackson Laboratory
Taconic Biosciences
Charles River Laboratories
Shanghai Model Organisms Center Inc.
Envigo
Biocytogen
Genoway
Crown Bioscience Inc. (JSR Corporation).
Cyagen
Applied stem cells
Ingenious Targeting Laboratory
PolyGene - Transgenic mice model company
Creative Biolabs
TransCure Bioservices
Champions Oncology Inc
Certis Oncology
Signature
Pharmaron
Laboratory Corporation of America Holdings
Gempharmatech
Janvier Labs
Harbour BioMed
jiaGou

Add To Cart

gouMai

Buy Now